Galderma Recalls Doxycycline Capsules Due to Labeling Errors
Galderma recalls Doxycycline USP Capsules 40 mg because some bottles have missing or incorrect lot numbers and expiration dates.
Recall notice
Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
Contact the company
What happened, in plain English
Galderma Laboratories, L.P. is recalling Doxycycline, USP Capsules 40 mg because the labeling on some bottles has incorrect or missing lot numbers and/or expiration dates. The product is packaged in 30-count bottles and marketed by Prasco Laboratories. This recall affects 71,340 bottles distributed nationwide. Read more at govinfonow.com/recall/42605-galderma-recalls-doxycycline-capsules-due-to-labeling-errors.
Source Summary by GovInfoNow · govinfonow.com/recall/42605-galderma-recalls-doxycycline-capsules-due-to-labeling-errors · Updated October 9, 2026 · FDA enforcement record: FDA #D-1031-2016
Cite this page
“Galderma Recalls Doxycycline Capsules Due to Labeling Errors.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42605-galderma-recalls-doxycycline-capsules-due-to-labeling-errors. Based on FDA recall #D-1031-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1031-2016%22&limit=1).
Why it’s dangerous
The primary issue is that some bottles lack valid lot numbers or expiration dates, which prevents users and healthcare providers from verifying the medication's freshness and authenticity. While the record does not specify a direct physical injury mechanism like fire or choking, incorrect labeling can lead to the use of expired medication or difficulty in tracking adverse events.
Who’s affected
Consumers who purchased Doxycycline USP Capsules 40 mg from pharmacies or retailers across the United States between the manufacture dates and the recall date. Patients relying on these specific lots may be affected if they cannot verify the expiration date.
How to tell if you have this one
Check your bottle of Doxycycline, USP Capsules 40 mg (Rx Only) for the NDC number 66993-815-30. Look specifically at the label for Lot numbers and Expiration dates; some bottles may have these fields blank or incorrect. Affected lots include Lot # 1496059A with an expiry of 08/31/2017 and Lot # AD9848A with an expiry of 11/30/2017.
- Brand
Galderma / Prasco- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1031-2016 (May 19, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1031-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.